Bouraoui Hatem, Trimeche Besma, Hajri Samia Ernez, Mahdhaoui Abdallah, Romdhane Meriem Ben, Jeridi Gouider
Department of Cardiology Farhat Hached Hospital 4000 Sousse, Tunisia.
Heart Views. 2014 Jul;15(3):65-7. doi: 10.4103/1995-705X.144780.
The aim of our study was to assess the delay of fibrinolysis in ST elevation myocardial infarction (STEMI) in our region and to identify characteristics associated with prolonged delay.
We analyzed clinical characteristics of a prospective cohort of unselected patients admitted for (STEMI). The study was conducted over three years 2007-2009 and 250 patients were included in a single center without capability of percutaneous coronary intervention.
The mean age of our patients was 58±13, 7 years. Ninety percent of our patients consult directly the emergency department and 61, (5%) of them were admitted within first 6 hours of onset of symptoms. Median time to reperfusion was 46 min. Predictor of this long delay to initiate fibrinolysis were inter-department decision OR 6; 95% CI 3,48-10,34, diabetes OR 2,25; 95% CI 1,28-3,96 age >58,4 years OR 1,97; 95% CI 1,19-3,25 and transfer from regional hospital to our center OR 1,78; 95% 1,03-3.07.
These results suggest that improvement in organization health care system can shorten delay to fibrinolysis in a center without percutaneous coronary intervention capability.
我们研究的目的是评估我们地区ST段抬高型心肌梗死(STEMI)患者纤溶治疗的延迟情况,并确定与延迟延长相关的特征。
我们分析了一组未经选择的因STEMI入院患者的前瞻性队列的临床特征。该研究在2007 - 2009年的三年间进行,纳入了250例患者,研究在一个没有经皮冠状动脉介入治疗能力的单一中心进行。
我们患者的平均年龄为58±13.7岁。90%的患者直接前往急诊科就诊,其中61例(5%)在症状发作后的前6小时内入院。再灌注的中位时间为46分钟。启动纤溶治疗延迟时间长的预测因素包括部门间决策(比值比[OR]为6;95%置信区间[CI]为3.48 - 10.34)、糖尿病(OR为2.25;95% CI为1.28 - 3.96)、年龄>58.4岁(OR为1.97;95% CI为1.19 - 3.25)以及从地区医院转至我们中心(OR为1.78;95% CI为1.03 - 3.07)。
这些结果表明,改善医疗保健系统的组织可以缩短在没有经皮冠状动脉介入治疗能力的中心进行纤溶治疗的延迟时间。